慢性肾脏病与人工髋关节周围骨折全髋关节置换患者的结局
基于大型全国数据库分析108,836例髋关节周围骨折住院患者,其中17,115例(15.7%)合并慢性肾脏病。CKD 1-3期、CKD 4-5期和终末期肾病均与院内死亡风险增加相关,且随着CKD严重程度增加,住院时间和费用呈阶梯式上升。作者认为需要在CKD 4-5期和终末期肾病的关节置换周围骨折患者中开展质量改进工作。
要点
- CKD 1-3期(AOR 1.28)、CKD 4-5期(AOR 2.00)和ESRD(AOR 4.20)均与院内死亡风险增加相关。
- 随着CKD严重程度增加,住院时间和费用呈阶梯式上升。
- 2016年至2020年,髋关节周围骨折患者中肾脏疾病总体患病率从14.6%升至16.3%,而ESRD从1.8%降至1.3%。
核心结论
- 晚期肾功能不全与髋关节周围骨折患者更差的术后结局和更高的医疗费用相关。
- 作者认为需要在合并CKD 4-5期和ESRD的关节置换周围骨折患者中开展质量改进工作。
研究设计与样本
- 利用大型全国数据库识别髋关节周围骨折住院患者,分为无CKD、早期CKD(CKD 1-3期)、晚期CKD(CKD 4-5期)和ESRD组。
- 共纳入108,836例髋关节周围骨折患者,其中17,115例(15.7%)合并CKD。
- 主要结局为院内死亡,次要结局包括围手术期并发症、住院时间、费用、非家庭出院和30天再入院。
- 采用非参数检验评估时间趋势,多变量逻辑回归和线性回归模型评估肾脏疾病严重程度与结局的关联。
主要发现
- CKD 1-3期(AOR 1.28,95%CI 1.05-1.55)、CKD 4-5期(AOR 2.00,95%CI 1.45-2.75)和ESRD(AOR 4.20,95%CI 2.93-6.03)均与院内死亡风险增加相关。
- CKD严重程度增加与住院时间和费用呈阶梯式增加相关。
- 2016年至2020年,髋关节周围骨折患者中肾脏疾病总体患病率从14.6%升至16.3%(P<0.001),ESRD患病率从1.8%降至1.3%(P=0.001)。
关键数值与推荐
- CKD 1-3期院内死亡的AOR为1.28(95%CI 1.05-1.55)。
- CKD 4-5期院内死亡的AOR为2.00(95%CI 1.45-2.75)。
- ESRD院内死亡的AOR为4.20(95%CI 2.93-6.03)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients who have end-stage renal disease (ESRD) and chronic kidney disease (CKD) have an increased risk of mortality and perioperative complications after primary total hip arthroplasty. The association between increasing severity of renal disease with clinical and financial end points in patients treated for hip periprosthetic fracture (PPF) is underexplored in the literature. METHODS: Hip PPF hospitalizations were identified using a large national database and grouped into non-CKD, early-stage CKD (CKD 1 to 3), advanced-stage CKD (CKD 4 to 5), and ESRD. The primary outcome of the study was in-hospital mortality. The secondary outcomes included perioperative complications, hospitalization length of stay, costs, non-home discharges, and 30-day readmissions. Nonparametric tests were used to assess temporal trends. Of 108,836 patients treated for PPF, 17,115 (15.7%) had CKD. The overall prevalence of renal disease in patients who had PPF increased significance from 2016 to 2020 (2020: 16.3% versus 2016: 14.6%, P < 0.001), whereas those who had ESRD decreased (2020: 1.3% versus 2016: 1.8%, P = 0.001). Multivariable logistic and linear regression models were used to evaluate the association of renal disease severity with outcomes of interest. RESULTS: Chronic kidney disease 1 to 3 (adjusted odds ratio [AOR] 1.28, 95% CI 1.05 to 1.55), CKD 4 to 5 (AOR 2.00, 95% CI 1.45 to 2.75), and ESRD (AOR 4.20, 95% CI 2.93 to 6.03) were all associated with increased odds of in-hospital mortality. The increased severity of CKD was associated with a stepwise increase in length of stay and cost. CONCLUSIONS: Advanced renal dysfunction was associated with worse postoperative outcomes and greater health care expenditures in patients undergoing management for PPF. Our findings warrant quality improvement efforts in arthroplasty PPF patients who had CKD 4 to 5 and ESRD.
引用
- Juels ML, Galoustian NA, Balian J, et al. Chronic Kidney Disease and Outcomes of Total Hip Arthroplasty Patients Who Have Periprosthetic Hip Fractures. J Arthroplasty. 2025. PMID: 41016611. doi:10.1016/j.arth.2025.09.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。